CBLL

Ceribell Inc

27.13

Oct 23 • 3:59 PM ET -0.27 (-0.99%)

27.13

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Healthcare Medical Devices USA Small NASD

Peers: NPCE NMTC IRTC BFLY LIVN PHG BWAY MDT ECOR AIFF

| Held by: VTI IWM VXF IWO VTWO SCHA FFSM IHI LFSC IWC

Scroll to Statements

Index	RUT
Market Cap	1.04B
Enterprise Value	933.90M
Income	-66.00M
Sales	101.96M
Book/sh	3.36
Cash/sh	3.37
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	327
IPO	Oct 11, 2024

P/E	-
Forward P/E	-
PEG	-
P/S	10.21
P/B	8.08
P/C	8.06
P/FCF	-
EV/EBITDA	-
EV/Sales	9.16
Quick Ratio	8.66
Current Ratio	9.05
Debt/Eq	0.17
LT Debt/Eq	0.16
Option/Short	Yes / Yes

EPS (ttm)	-1.76
EPS next Y	-1.61
EPS next Q	-0.51
EPS this Y	-35.12%
EPS next Y	18.47%
EPS next 5Y	2.54%
EPS past 3/5Y	-10.19% -
Sales past 3/5Y	50.90% -
EPS Y/Y TTM	-28.13%
Sales Y/Y TTM	31.70%
EPS Q/Q	-34.77%
Sales Q/Q	32.54%
Earnings	Nov 03 AMC
EPS/Sales Surpr.	-8.23% 3.01%

Insider Own	33.38%
Insider Trans	-4.22%
Inst Own	67.17%
Inst Trans	3.24%
ROA	-35.29%
ROE	-43.93%
ROIC	-44.28%
Gross Margin	88.90%
Oper. Margin	-68.62%
Profit Margin	-64.73%
SMA20	7.17%
SMA50	10.16%
SMA200	31.21%
Trades

Shs Outstand	38.22M
Shs Float	25.57M
Short Float	7.89%
Short Ratio	4.95
Short Interest	2.02M
52W High	28.11 -3.49%
52W Low	10.85 150.05%
Volatility	5.79% 5.43%
ATR (14)	1.35
RSI (14)	59.41
Beta	0.88
Rel Volume	1.22
Avg Volume	407.70K
Volume	497,602

Perf Week	8.35%
Perf Month	13.90%
Perf Quarter	49.64%
Perf Half Y	28.09%
Perf YTD	23.71%
Perf Year	109.66%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	28.57
Prev Close	27.40
Price	27.13
Change %	-0.99%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Initiated	Raymond James	Strong Buy	$19
Jun-24-25	Initiated	BTIG Research	Buy	$30
Apr-04-25	Initiated	Ladenburg Thalmann	Buy	$32
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	TD Cowen	Buy	$31
Nov-05-24	Initiated	JP Morgan	Overweight	$32
Nov-05-24	Initiated	Canaccord Genuity	Buy	$30
Nov-05-24	Initiated	BofA Securities	Buy	$32

Oct-20-26 04:05PM	Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026 (GlobeNewswire) +6.46%
Sep-30-26 07:00AM	Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis (GlobeNewswire)
Aug-11-26 01:02AM	CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ... (GuruFocus.com) +10.41%
Aug-10-26 04:05PM	Ceribell Reports Second Quarter 2026 Financial Results (GlobeNewswire)
07:00AM	Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review (GlobeNewswire)
09:19AM	Loading…
Aug-07-26 09:19AM	What To Expect From CeriBell Inc (CBLL) Q2 2026 Earnings (GuruFocus.com)
Aug-04-26 09:43AM	CeriBell Inc (CBLL) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-03-26 08:45AM	CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System (InvestorsHub)
07:00AM	Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System (GlobeNewswire)
Jul-29-26 07:00AM	Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O'Keefe (GlobeNewswire)
Jul-28-26 04:05PM	Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference (GlobeNewswire)
Jul-20-26 04:05PM	Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026 (GlobeNewswire)
Jun-08-26 07:00AM	Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes (GlobeNewswire)
May-20-26 04:05PM	Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference (GlobeNewswire) +6.72%
May-12-26 03:07AM	CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ... (GuruFocus.com) -16.50%
04:05PM	Loading…
May-11-26 04:05PM	Ceribell Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-08-26 09:17AM	What To Expect From CeriBell Inc (CBLL) Q1 2026 Earnings (GuruFocus.com)
Apr-29-26 04:05PM	Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference (GlobeNewswire) -7.45%
Apr-20-26 04:05PM	Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026 (GlobeNewswire)
Mar-07-26 11:15AM	CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium (MarketBeat)
10:23AM	CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot (MarketBeat)
Mar-02-26 10:23AM	Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord (Insider Monkey)
Feb-25-26 12:03AM	CeriBell Inc (CBLL) Q4 2025 Earnings Call Highlights: Revenue Surge and Market Expansion Amid ... (GuruFocus.com)
Feb-24-26 10:06PM	CeriBell Q4 Earnings Call Highlights (MarketBeat)
09:55PM	CeriBell, Inc. (CBLL) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-23-26 07:26AM	CeriBell Inc (CBLL) Q4 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-18-26 04:05PM	Ceribell to Participate in Upcoming March Investor Conferences (GlobeNewswire)
Feb-10-26 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
Jan-14-26 09:21AM	CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion (MarketBeat)
12:34PM	Loading…
Jan-06-26 12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
Jan-05-26 08:00AM	Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution (GlobeNewswire)
Dec-30-25 04:05PM	Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-25 10:02AM	CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution (Zacks)
09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire)
Dec-09-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution (GlobeNewswire)
Nov-24-25 08:00AM	Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates (GlobeNewswire)
Nov-19-25 04:05PM	Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-06-25 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-05-25 12:06AM	CeriBell Inc (CBLL) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +7.88%
Nov-04-25 06:05PM	CeriBell, Inc. (CBLL) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Ceribell Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-29-25 10:00AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks) -6.24%
Oct-28-25 10:00AM	CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-21-25 04:05PM	Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 (GlobeNewswire) +7.04%
Sep-22-25 08:00AM	Medtech Leader Erica Rogers Joins Ceribell Board of Directors (GlobeNewswire)
Aug-13-25 12:08PM	J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT (Insider Monkey)
Aug-05-25 04:05PM	Ceribell Reports Second Quarter 2025 Financial Results (GlobeNewswire) -15.25%
Jul-29-25 04:05PM	Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-22-25 04:05PM	Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-07-25 04:42PM	Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware (GlobeNewswire) -9.14%
Jun-20-25 09:11AM	AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape (PR Newswire)
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive)
May-20-25 04:05PM	Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference (GlobeNewswire)
May-09-25 03:43AM	CeriBell Inc (CBLL) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com) -6.61%
May-08-25 04:05PM	Ceribell Reports First Quarter 2025 Financial Results (GlobeNewswire) +6.81%
Apr-30-25 04:05PM	Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference (GlobeNewswire)
08:00AM	Ceribell Receives FedRAMP High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems (GlobeNewswire)
Apr-24-25 04:05PM	Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 (GlobeNewswire)
Apr-23-25 02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-21-25 05:00AM	Ceribell wins FDA nod for algorithm to detect pediatric seizures (MedTech Dive)
Apr-16-25 10:40AM	CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm (Zacks)
Apr-15-25 08:00AM	FDA Clears Ceribell's Clarity Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older (GlobeNewswire)
Apr-07-25 01:04PM	CeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It Today (Seeking Alpha)
Apr-05-25 11:00AM	Markets Watch Out For Core CPI With Big Banks Set To Report Earnings (Seeking Alpha)
Feb-26-25 02:15AM	CeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ... (GuruFocus.com)
Feb-25-25 04:05PM	Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:05PM	Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference (GlobeNewswire)
Feb-11-25 04:05PM	Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 (GlobeNewswire)
Dec-23-24 04:05PM	Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-19-24 08:00AM	Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing (GlobeNewswire)
07:01AM	Meet the biophysicist whose seizure-detection company is using AI to get a better read on peoples brains (FastCompany)
Nov-13-24 11:55PM	Ceribell, Inc. Reports Strong Q3 2024 Growth (TipRanks)
Nov-12-24 04:05PM	Ceribell Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs (GlobeNewswire)
Nov-07-24 04:05PM	Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Nov-06-24 06:31AM	Ceribell initiated with a Buy at BofA on differentiated AI algorithm (TipRanks)
Oct-29-24 04:05PM	Ceribell to Report Third Quarter 2024 Financial Results on November 12, 2024 (PR Newswire)
Oct-18-24 01:01AM	TPG GP A, LLC Acquires New Stake in CeriBell Inc (GuruFocus.com)
Oct-16-24 04:05PM	New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG (PR Newswire)
Oct-15-24 05:00PM	CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (PR Newswire)
Oct-14-24 06:45AM	Opening Day: Another trio of biotech IPOs make Friday debut (TipRanks)
Oct-11-24 05:00PM	CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs (Bloomberg)
10:15AM	CeriBell IPO: Stock price soars as AI brain-monitoring headband maker debuts on Nasdaq (FastCompany)
08:45AM	Upstream Bio Leads Life Sciences IPOs With Upsized Listing (Bloomberg)
Oct-10-24 11:27PM	CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering (PR Newswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Woo Raymond	Chief Technology Officer	Oct 01 '26	Option Exercise	3.65	4,887	17,862	208,005	Oct 02 05:19 PM
Woo Raymond	Chief Technology Officer	Oct 01 '26	Sale	24.38	4,887	119,145	203,118	Oct 02 05:19 PM
Woo Raymond	Officer	Oct 01 '26	Proposed Sale	24.38	4,887	119,145		Oct 01 10:45 AM
Chao Xingjuan	President and CEO	Sep 15 '26	Sale	25.03	20,846	521,775	746,345	Sep 17 08:45 PM
Blumberg Scott	Chief Financial Officer	Sep 15 '26	Option Exercise	9.41	846	7,961	147,446	Sep 17 08:40 PM
Blumberg Scott	Chief Financial Officer	Sep 15 '26	Sale	25.00	846	21,150	146,600	Sep 17 08:40 PM
Blumberg Scott	Officer	Sep 15 '26	Proposed Sale	25.00	846	21,151		Sep 15 04:36 PM
Chao Xingjuan	Officer	Sep 15 '26	Proposed Sale	25.03	20,846	521,773		Sep 15 04:29 PM
Foehr David	Senior VP, Finance and PAO	Sep 08 '26	Option Exercise	4.70	7,500	35,250	41,644	Sep 10 08:27 PM
Foehr David	Senior VP, Finance and PAO	Sep 08 '26	Sale	24.25	9,255	224,451	34,144	Sep 10 08:27 PM
Woo Raymond	Chief Technology Officer	Sep 08 '26	Option Exercise	2.76	13,276	36,653	208,005	Sep 10 08:23 PM
Woo Raymond	Chief Technology Officer	Sep 08 '26	Sale	24.33	4,887	118,901	203,118	Sep 10 08:23 PM
Foehr David	Officer	Sep 08 '26	Proposed Sale	24.33	9,255	225,174		Sep 08 01:23 PM
Woo Raymond	Officer	Sep 08 '26	Proposed Sale	24.33	4,887	118,901		Sep 08 09:42 AM
Chao Xingjuan	President and CEO	Sep 02 '26	Option Exercise	4.70	25,000	117,500	806,731	Sep 04 06:13 PM
Chao Xingjuan	President and CEO	Sep 02 '26	Sale	24.61	39,540	973,079	767,191	Sep 04 06:13 PM
Blumberg Scott	Chief Financial Officer	Sep 02 '26	Option Exercise	9.41	652	6,135	147,252	Sep 04 06:12 PM
Blumberg Scott	Chief Financial Officer	Sep 02 '26	Sale	25.00	652	16,300	146,600	Sep 04 06:12 PM
Chao Xingjuan	Officer	Sep 02 '26	Proposed Sale	24.61	39,540	973,090		Sep 02 04:59 PM
Blumberg Scott	Officer	Sep 02 '26	Proposed Sale	25.00	652	16,300		Sep 02 04:38 PM
Manni Joseph S.	Chief Revenue Officer	Aug 21 '26	Sale	24.02	1,361	32,691	55,956	Aug 25 07:29 PM
Foehr David	Senior VP, Finance and PAO	Aug 21 '26	Sale	24.02	993	23,852	36,758	Aug 25 07:27 PM
Foehr David	Senior VP, Finance and PAO	Aug 24 '26	Sale	23.95	859	20,573	35,899	Aug 25 07:27 PM
Woo Raymond	Chief Technology Officer	Aug 21 '26	Sale	24.02	1,979	47,536	194,729	Aug 25 07:25 PM
Blumberg Scott	Chief Financial Officer	Aug 21 '26	Sale	24.02	1,521	36,534	146,600	Aug 25 07:24 PM
Chao Xingjuan	President and CEO	Aug 21 '26	Sale	24.02	6,068	145,753	781,731	Aug 25 07:20 PM
Foehr David	Officer	Aug 24 '26	Proposed Sale	23.95	859	20,573		Aug 24 09:39 AM
Blumberg Scott	Officer	Aug 21 '26	Proposed Sale	24.02	1,521	36,537		Aug 21 05:05 PM
Foehr David	Officer	Aug 21 '26	Proposed Sale	24.02	993	23,854		Aug 21 05:04 PM
Woo Raymond	Officer	Aug 21 '26	Proposed Sale	24.02	1,979	47,539		Aug 21 04:54 PM
Manni Joseph S.	Officer	Aug 21 '26	Proposed Sale	24.02	1,361	32,694		Aug 21 04:52 PM
Chao Xingjuan	Officer	Aug 21 '26	Proposed Sale	24.02	6,068	145,764		Aug 21 04:51 PM
Blumberg Scott	Chief Financial Officer	Aug 19 '26	Option Exercise	8.54	33,512	286,245	181,633	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 18 '26	Option Exercise	6.13	990	6,066	149,111	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 19 '26	Sale	25.03	33,512	838,805	148,121	Aug 20 08:55 PM
Blumberg Scott	Chief Financial Officer	Aug 18 '26	Sale	25.00	990	24,750	148,121	Aug 20 08:55 PM
Chao Xingjuan	President and CEO	Aug 19 '26	Sale	25.03	31,415	786,317	787,799	Aug 20 06:51 PM
Chao Xingjuan	President and CEO	Aug 18 '26	Sale	25.00	2,199	54,975	819,214	Aug 20 06:51 PM
Blumberg Scott	Officer	Aug 19 '26	Proposed Sale	25.03	33,512	838,820		Aug 19 04:29 PM
Chao Xingjuan	Officer	Aug 19 '26	Proposed Sale	25.03	31,415	786,364		Aug 19 04:29 PM
Chao Xingjuan	Officer	Aug 18 '26	Proposed Sale	25.00	2,199	54,975		Aug 18 04:57 PM
Blumberg Scott	Officer	Aug 18 '26	Proposed Sale	25.00	990	24,750		Aug 18 04:15 PM
Chao Xingjuan	President and CEO	Aug 13 '26	Option Exercise	3.31	33,096	109,385	821,413	Aug 17 06:27 PM
Taylor Joseph Michael	Director	Aug 13 '26	Sale	23.40	13,095	306,423	48,478	Aug 14 02:37 PM
Taylor Joseph Michael	Director	Aug 13 '26	Proposed Sale	22.91	13,095	300,000		Aug 13 10:29 AM
Chao Xingjuan	President and CEO	Aug 03 '26	Option Exercise	4.70	25,000	117,500	827,317	Aug 05 03:31 PM
Chao Xingjuan	President and CEO	Aug 03 '26	Sale	18.32	39,000	714,480	788,317	Aug 05 03:31 PM
Chao Xingjuan	Officer	Aug 03 '26	Proposed Sale	18.00	39,000	702,000		Aug 03 10:02 AM
Chao Xingjuan	President and CEO	Jul 07 '26	Option Exercise	4.70	25,000	117,500	825,871	Jul 09 12:34 PM
Chao Xingjuan	President and CEO	Jul 07 '26	Sale	19.90	39,000	776,100	802,317	Jul 09 12:34 PM
Chao Xingjuan	Officer	Jul 07 '26	Proposed Sale	20.00	39,000	780,000		Jul 07 10:01 AM
BURKE WILLIAM W	Director	Jun 30 '26	Sale	19.84	2,207	43,787	23,022	Jul 02 12:08 PM
TPG GP A, LLC	Former 10% Owner	Jun 26 '26	Sale	20.12	202,368	4,071,705	3,765,054	Jun 30 04:29 PM
BURKE WILLIAM W	Director	Jun 30 '26	Proposed Sale	19.84	2,207	43,787		Jun 30 09:49 AM
Taylor Joseph Michael	Director	Jun 11 '26	Sale	18.41	5,500	101,255	61,573	Jun 15 01:48 PM
Taylor Joseph Michael	Director	Jun 11 '26	Proposed Sale	18.41	5,500	101,255		Jun 11 10:15 AM
Chao Xingjuan	President and CEO	Jun 08 '26	Option Exercise	4.70	25,000	117,500	839,871	Jun 10 12:53 PM
Chao Xingjuan	President and CEO	Jun 08 '26	Sale	18.33	39,000	714,870	816,317	Jun 10 12:53 PM
Chao Xingjuan	Officer	Jun 08 '26	Proposed Sale	18.36	39,000	716,040		Jun 08 02:23 PM
Manni Joseph S.	Chief Revenue Officer	May 21 '26	Sale	18.00	1,378	24,804	56,291	May 26 04:22 PM
Foehr David	Senior VP, Finance and PAO	May 21 '26	Sale	18.00	987	17,766	38,613	May 26 04:18 PM
Foehr David	Senior VP, Finance and PAO	May 22 '26	Sale	18.80	862	16,206	37,751	May 26 04:18 PM
Woo Raymond	Chief Technology Officer	May 21 '26	Sale	18.00	1,966	35,388	195,682	May 26 04:17 PM
Blumberg Scott	Chief Financial Officer	May 21 '26	Sale	18.00	1,387	24,966	147,683	May 26 04:16 PM
Chao Xingjuan	President and CEO	May 21 '26	Sale	18.00	6,030	108,540	830,317	May 26 04:15 PM
Foehr David	Officer	May 22 '26	Proposed Sale	18.80	862	16,206		May 22 10:29 AM
Foehr David	Officer	May 21 '26	Proposed Sale	18.00	987	17,762		May 21 04:10 PM
Woo Raymond	Officer	May 21 '26	Proposed Sale	18.00	1,966	35,380		May 21 04:04 PM
Chao Xingjuan	Officer	May 21 '26	Proposed Sale	18.00	6,030	108,515		May 21 03:53 PM
Manni Joseph S.	Officer	May 21 '26	Proposed Sale	18.00	1,378	24,798		May 21 03:51 PM
Blumberg Scott	Officer	May 21 '26	Proposed Sale	18.00	1,387	24,960		May 21 03:15 PM
BURKE WILLIAM W	Director	May 08 '26	Proposed Sale	26.01	4,823	125,446		May 08 10:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Option Exercise	4.70	25,000	117,500	859,901	May 07 11:09 AM
Chao Xingjuan	President and CEO	May 05 '26	Sale	20.10	39,000	783,973	836,347	May 07 11:09 AM
Chao Xingjuan	Officer	May 05 '26	Proposed Sale	20.10	39,000	784,000		May 05 04:25 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Option Exercise	4.37	11,104	48,575	204,259	May 04 07:05 PM
Woo Raymond	Chief Technology Officer	May 01 '26	Sale	20.44	11,104	226,928	197,648	May 04 07:05 PM
Woo Raymond	Officer	May 01 '26	Proposed Sale	20.16	11,104	223,857		May 01 03:10 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Option Exercise	4.70	25,000	117,500	873,901	Apr 08 12:47 PM
Chao Xingjuan	President and CEO	Apr 06 '26	Sale	18.40	39,000	717,600	850,347	Apr 08 12:47 PM
Chao Xingjuan	Officer	Apr 06 '26	Proposed Sale	18.40	39,000	717,551		Apr 06 04:27 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Option Exercise	4.37	11,112	48,605	173,527	Apr 03 01:55 PM
Woo Raymond	Chief Technology Officer	Apr 01 '26	Sale	18.56	11,112	206,244	166,912	Apr 03 01:55 PM
Woo Raymond	Officer	Apr 01 '26	Proposed Sale	18.56	11,112	206,261		Apr 01 04:21 PM
Chao Xingjuan	President and CEO	Mar 25 '26	Option Exercise	2.72	55,628	151,397	766,792	Mar 27 12:25 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Option Exercise	4.70	4,560	21,432	20,953	Mar 05 02:22 PM
Foehr David	Senior VP, Finance and PAO	Mar 03 '26	Sale	17.80	4,560	81,168	17,550	Mar 05 02:22 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Sale	17.80	827	14,721	18,749	Mar 05 02:20 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Option Exercise	4.70	25,000	117,500	734,718	Mar 05 02:18 PM
Chao Xingjuan	President and CEO	Mar 03 '26	Sale	17.45	39,000	680,564	711,164	Mar 05 02:18 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Option Exercise	4.37	11,112	48,605	173,527	Mar 04 01:28 PM
Woo Raymond	Chief Technology Officer	Mar 02 '26	Sale	18.25	8,087	147,602	166,912	Mar 04 01:28 PM
Chao Xingjuan	Officer	Mar 03 '26	Proposed Sale	17.80	39,000	694,200		Mar 03 01:46 PM
Foehr David	Officer	Mar 03 '26	Proposed Sale	17.80	4,560	81,168		Mar 03 12:17 PM
ROBERTSON REBECCA B	Director	Mar 03 '26	Proposed Sale	17.80	827	14,721		Mar 03 11:37 AM
Woo Raymond	Officer	Mar 02 '26	Proposed Sale	18.14	11,112	201,572		Mar 02 11:56 AM
Foehr David	Senior VP, Finance and PAO	Feb 24 '26	Sale	19.98	781	15,604	17,550	Feb 25 04:46 PM
Foehr David	Senior VP, Finance and PAO	Feb 23 '26	Sale	19.79	569	11,261	18,331	Feb 25 04:46 PM
Manni Joseph S.	Chief Revenue Officer	Feb 23 '26	Sale	19.79	768	15,199	26,933	Feb 25 04:46 PM
Woo Raymond	Chief Technology Officer	Feb 23 '26	Sale	19.79	705	13,952	166,912	Feb 25 04:45 PM

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Co-FounderDr. Xingjuan Chao Ph.D.

Ph.D.Dr. Josef Parvizi M.D.

Chief Financial OfficerMr. Scott Blumberg

Chief Technology OfficerDr. Raymond Woo Ph.D.

M.B.A.Ms. Louisa Daniels J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CBLL

Ceribell Inc

Upgrade your Finviz experience